Literature DB >> 22814311

Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study.

Erik Thunnissen1, Mary Beth Beasley, Alain C Borczuk, Elisabeth Brambilla, Lucian R Chirieac, Sanja Dacic, Douglas Flieder, Adi Gazdar, Kim Geisinger, Philip Hasleton, Yuichi Ishikawa, Keith M Kerr, Sylvie Lantejoul, Yoshiro Matsuno, Yuko Minami, Andre L Moreira, Noriko Motoi, Andrew G Nicholson, Masayuki Noguchi, Daisuke Nonaka, Giuseppe Pelosi, Iver Petersen, Natasha Rekhtman, Victor Roggli, William D Travis, Ming S Tsao, Ignacio Wistuba, Haodong Xu, Yasushi Yatabe, Maureen Zakowski, Birgit Witte, Dirk Joop Kuik.   

Abstract

Histological subtyping of pulmonary adenocarcinoma has recently been updated based on predominant pattern, but data on reproducibility are required for validation. This study first assesses reproducibility in subtyping adenocarcinomas and then assesses further the distinction between invasive and non-invasive (wholly lepidic) pattern of adenocarcinoma, among an international group of pulmonary pathologists. Two ring studies were performed using a micro-photographic image-based method, evaluating selected images of lung adenocarcinoma histologic patterns. In the first study, 26 pathologists reviewed representative images of typical and 'difficult' histologic patterns. A total number of scores for the typical patterns combined (n=94) and the difficult cases (n=21) were 2444 and 546, respectively. The mean kappa score (±s.d.) for the five typical patterns combined and for difficult cases were 0.77±0.07 and 0.38±0.14, respectively. Although 70% of the observers identified 12-65% of typical images as single pattern, highest for solid and least for micropapillary, recognizing the predominant pattern was achieved in 92-100%, of the images except for micropapillary pattern (62%). For the second study on invasion, identified as a key problem area from the first study, 28 pathologists submitted and reviewed 64 images representing typical as well as 'difficult' examples. The kappa for typical and difficult cases was 0.55±0.06 and 0.08±0.02, respectively, with consistent subdivision by the same pathologists into invasive and non-invasive categories, due to differing interpretation of terminology defining invasion. In pulmonary adenocarcinomas with classic morphology, which comprise the majority of cases, there is good reproducibility in identifying a predominant pattern and fair reproducibility distinguishing invasive from in-situ (wholly lepidic) patterns. However, more precise definitions and better education on interpretation of existing terminology are required to improve recognition of purely in-situ disease, this being an area of increasing importance.

Entities:  

Mesh:

Year:  2012        PMID: 22814311      PMCID: PMC5164925          DOI: 10.1038/modpathol.2012.106

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  12 in total

1.  EU-USA pathology panel for uniform diagnosis in randomised controlled trials for HRCT screening in lung cancer.

Authors:  F B Thunnissen; K M Kerr; E Brambilla; C E Comin; W A Franklin; B Guldhammerskov; W H Westra; D B Flieder
Journal:  Eur Respir J       Date:  2006-08-09       Impact factor: 16.671

2.  Lung cancer staging. A critical evaluation.

Authors:  A R Feinstein; C K Wells
Journal:  Clin Chest Med       Date:  1982-05       Impact factor: 2.878

3.  Reproducibility of the diagnosis of small adenocarcinoma of the lung and usefulness of an educational program for the diagnostic criteria.

Authors:  Masayuki Noguchi; Yuko Minami; Tatsuo Iijima; Yoshihiro Matsuno
Journal:  Pathol Int       Date:  2005-01       Impact factor: 2.534

Review 4.  Large cell carcinoma of the lung.

Authors:  R Yesner
Journal:  Semin Diagn Pathol       Date:  1985-11       Impact factor: 3.464

5.  Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases.

Authors:  V L Roggli; R T Vollmer; S D Greenberg; M H McGavran; H J Spjut; R Yesner
Journal:  Hum Pathol       Date:  1985-06       Impact factor: 3.466

6.  Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases.

Authors:  Akihiko Yoshizawa; Noriko Motoi; Gregory J Riely; Cami S Sima; William L Gerald; Mark G Kris; Bernard J Park; Valerie W Rusch; William D Travis
Journal:  Mod Pathol       Date:  2011-01-21       Impact factor: 7.842

7.  Reproducibility of tumour typing of lung carcinomas performed according to WHO's recommendation.

Authors:  I Dale; P Lexow; F Skjørten; J T Stenwig; P Brandtzaeg
Journal:  APMIS       Date:  1989-04       Impact factor: 3.205

8.  Interobserver variability in histopathologic subtyping and grading of pulmonary adenocarcinoma.

Authors:  J B Sørensen; F R Hirsch; A Gazdar; J E Olsen
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

9.  The value of the 1981 WHO histological classification in inter-observer reproducibility and changing pattern of lung cancer.

Authors:  O Campobasso; A Andrion; M Ribotta; G Ronco
Journal:  Int J Cancer       Date:  1993-01-21       Impact factor: 7.396

10.  Diagnostic agreement in the histopathological evaluation of lung cancer tissue in a population-based case-control study.

Authors:  Andreas Stang; Hermann Pohlabeln; Klaus M Müller; Ingeborg Jahn; Klaus Giersiepen; Karl-Heinz Jöckel
Journal:  Lung Cancer       Date:  2006-02-14       Impact factor: 5.705

View more
  66 in total

Review 1.  [Lung cancer. Developments, concepts and preview of the new WHO classification].

Authors:  I Petersen; A Warth
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

2.  The evolving role of the pathologist in the management of lung cancer.

Authors:  Adi F Gazdar
Journal:  Lung Cancer Manag       Date:  2012

3.  Associations between mutations and histologic patterns of mucin in lung adenocarcinoma: invasive mucinous pattern and extracellular mucin are associated with KRAS mutation.

Authors:  Kyuichi Kadota; Yi-Chen Yeh; Sandra P D'Angelo; Andre L Moreira; Deborah Kuk; Camelia S Sima; Gregory J Riely; Maria E Arcila; Mark G Kris; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  Am J Surg Pathol       Date:  2014-08       Impact factor: 6.394

4.  Pulmonary adenocarcinoma histology.

Authors:  Erik Thunnissen
Journal:  Transl Lung Cancer Res       Date:  2012-12

5.  Implications of the Eighth Edition of the TNM Proposal: Invasive Versus Total Tumor Size for the T Descriptor in Pathologic Stage I-IIA Lung Adenocarcinoma.

Authors:  Koji Kameda; Takashi Eguchi; Shaohua Lu; Yang Qu; Kay See Tan; Kyuichi Kadota; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2018-09-07       Impact factor: 15.609

6.  Software performance in segmenting ground-glass and solid components of subsolid nodules in pulmonary adenocarcinomas.

Authors:  Julien G Cohen; Jin Mo Goo; Roh-Eul Yoo; Chang Min Park; Chang Hyun Lee; Bram van Ginneken; Doo Hyun Chung; Young Tae Kim
Journal:  Eur Radiol       Date:  2016-04-05       Impact factor: 5.315

7.  Retrospective assessment of interobserver agreement and accuracy in classifications and measurements in subsolid nodules with solid components less than 8mm: which window setting is better?

Authors:  Roh-Eul Yoo; Jin Mo Goo; Eui Jin Hwang; Soon Ho Yoon; Chang Hyun Lee; Chang Min Park; Soyeon Ahn
Journal:  Eur Radiol       Date:  2016-07-25       Impact factor: 5.315

8.  Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

Authors:  Ming-Sound Tsao; Sophie Marguet; Gwénaël Le Teuff; Sylvie Lantuejoul; Frances A Shepherd; Lesley Seymour; Robert Kratzke; Stephen L Graziano; Helmut H Popper; Rafael Rosell; Jean-Yves Douillard; Thierry Le-Chevalier; Jean-Pierre Pignon; Jean-Charles Soria; Elisabeth M Brambilla
Journal:  J Clin Oncol       Date:  2015-04-27       Impact factor: 44.544

Review 9.  Histopathologic and molecular approach to staging of multiple lung nodules.

Authors:  Frank Schneider; Sanja Dacic
Journal:  Transl Lung Cancer Res       Date:  2017-10

10.  Prediction of lung cancer histological types by RT-qPCR gene expression in FFPE specimens.

Authors:  Matthew D Wilkerson; Jason M Schallheim; D Neil Hayes; Patrick J Roberts; Roy R L Bastien; Michael Mullins; Xiaoying Yin; C Ryan Miller; Leigh B Thorne; Katherine B Geiersbach; Kenneth L Muldrew; William K Funkhouser; Cheng Fan; Michele C Hayward; Steven Bayer; Charles M Perou; Philip S Bernard
Journal:  J Mol Diagn       Date:  2013-05-20       Impact factor: 5.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.